Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19

22nd June 2020

FDA Approvals

Kite Receives European Medicines Agency Approval for CAR T Cell Therapy Manufacturing Facility in Europe

15th June 2020

Home Category Drug Development FDA Approvals

FDA Approvals

FDA Approves Merck’s RECARBRIO for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

by Content Team

8th June 2020

European Commission Approves Mercks DELSTRIGO

Merck, known as MSD outside the United States and Canada, announced that the U.S. FDA has approved a supplemental New...

Sun Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients

by Content Team

5th June 2020

Sun Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients

Sun Pharmaceutical Industries Ltd. has announced that it has received approval from the Drugs Controller General of India (DCGI) to...

FDA approves Roche’s Tecentriq in combination with Avastin for people with the most common form of liver cancer

by Content Team

4th June 2020

Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza

Roche announced that the US FDA has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of people...

FDA Approves Ticagrelor to Reduce Risk of First Heart Attack, Stroke in Patients with Coronary Artery Disease

by Content Team

4th June 2020

FDA Approves Ticagrelor to Reduce Risk of First Heart Attack, Stroke in Patients with Coronary Artery Disease

AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke...

AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ for the Treatment of Adults with Active Psoriatic Arthritis

by Content Team

2nd June 2020

AbbVie , a research-based global biopharmaceutical company, announced that it has submitted applications for a new indication to the U.S....

FDA Approves Eli Lilly Precision Oncology Treatment for Certain Lung and Thyroid Cancers

by Content Team

12th May 2020

FDA Approves Eli Lilly Precision Oncology Treatment for Certain Lung and Thyroid Cancers

Eli Lilly is moving quickly to get a newly-approved precision oncology treatment for certain lung and thyroid cancers into the...

Quotient Limited Announces CE Mark for its SARS-CoV-2 Antibody Microarray

by Content Team

4th May 2020

Quotient Limited Announces CE Mark for its SARS-CoV-2 Antibody Microarray

Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, announced that it has completed the process for declaring conformity...

Recipharm supports FDA approval of Perrigos AB-rated generic product

by Content Team

12th March 2020

Recipharm supports FDA approval of Perrigos AB-rated generic product

Recipharm, a leading contract development and manufacturing organisation (CDMO), is pleased to note the FDA’s approval of Perrigo’s AB-rated generic...

Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC

by Content Team

24th January 2020

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug...